We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Microfluidic System Enables Early Cancer Diagnosis Using Simple Blood Tests

By LabMedica International staff writers
Posted on 31 Jul 2025

Circulating tumor cells (CTCs), which break off from primary tumors and travel through the bloodstream, pose a significant risk by forming secondary tumors in other organs. More...

Detecting and analyzing these cells can play a crucial role in diagnosing and treating various cancers. However, the efficient capture of CTCs from blood has proven to be difficult, especially given the complexities and costs associated with incorporating antibodies into micro-sized devices. Although microfluidic systems using antibodies have shown promise, incorporating antibodies into specific regions of microscale devices involves complex chemical processes, ultimately raising production costs and hindering scalability. Now, scientists have developed a simple, cost-efficient microdevice that can detect cancer cells from blood with high sensitivity.

This novel microfluidic diagnostic device, developed by researchers at Chiba University (Chiba, Japan), incorporates microcone arrays to enhance the capture of cancer cells from blood. The team fabricated the device by imprinting polycarbonate (PC) sheets with microcone arrays using thermal nanoimprint lithography (T-NIL), a heat-based microfabrication technique. These microcones, approximately 30 micrometers in size, were arranged in a hexagonal pattern and featured nanometer-scale surface roughness that allowed for efficient binding of anti-human epithelial cell adhesion molecule antibodies. The antibody-coated PC sheets were sandwiched between a glass slide and a flat plate to form microchannels. The scientists tested various orientation angles of the microcone arrays within the microchannels to evaluate their influence on cancer cell capture behavior.

During experimental testing, the microfluidic device successfully captured human breast cancer (MCF-7) and human lung cancer (A549) cells from blood samples. The findings, published in Lab on a Chip, show that the device maintained a capture efficiency of over 90% for MCF-7 cells even at high flow rates, particularly when microcone orientation angles were set at 15° or 30°. To further demonstrate the system’s diagnostic capability, the researchers also performed immunostaining using fluorescent dyes to label and observe specific proteins in the captured cells. The labeled cancer cells remained trapped within the microchannels and could be easily distinguished from normal cells under fluorescence microscopy. This diagnostic device presents a highly sensitive and minimally invasive approach to cancer detection. It may also aid in monitoring treatment efficacy and identifying cancer recurrence through simple blood tests.

"We hope that through our new microfluidic system, even simple blood tests can be utilized to aid in the early diagnosis of cancer. It may also be useful for verifying the effectiveness of cancer treatment and monitoring recurrence after treatment," said Professor Masumi Yamada, lead developer of the device.

Related Links:
Chiba University


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
New
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Early and effective screening for gestational diabetes mellitus is becoming increasingly important (Photo courtesy of Shutterstock)

First-Trimester Blood Test Accurately Predicts Gestational Diabetes

Gestational diabetes mellitus (GDM) affects many pregnancies and is typically detected midway through pregnancy, often too late to prevent complications. Women diagnosed late face increased risks such... Read more

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.